Avelumab real-world use in advanced Merkel cell carcinoma: a systematic review and non-comparative meta-analysis

Key Points

• To evaluate the real-world effectiveness of avelumab in treating advanced Merkel cell carcinoma.
• Conducted a systematic review of available literature
• Performed a non-comparative meta-analysis of data on avelumab
• Assessed treatment outcomes in advanced Merkel cell carcinoma patients.
• Supported broader application of avelumab in clinical settings
• Highlighted positive outcomes in treatment efficacy for advanced MCC.